Concepedia

Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data

Tjeerd van Staa, Deven Patel, Arlene M. Gallagher, Marie L. De Bruin

Diabetologia · 2011 · 125 citations · 27 references

DOIFull text

Open access

Concepts

References

27

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

JAMA · 2002 · 15.8K citations · Full text

, , +17

Metformin and reduced risk of cancer in diabetic patients

Josie Evans, Louise A. Donnelly, Alistair Emslie‐Smith et al. · BMJ · 2005 · 2.4K citations · Full text

, , +14

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

Wayne A. Ray · American Journal of Epidemiology · 2003 · 1.6K citations · Full text

, , +12

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

C. J. Currie, C Poole, E.A.M. Gale · Diabetologia · 2009 · 1.1K citations · Full text

, , +13

New Users of Metformin Are at Low Risk of Incident Cancer

Gillian Libby, Louise A. Donnelly, Peter T. Donnan et al. · Diabetes Care · 2009 · 986 citations · Full text

, , +13